Search results
Built on the foundation of caring for life, Cipla ensures access to quality & affordable medicines through 1500+ products across various therapeutic categories.
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions.
Cipla is a leading pharmaceutical company that provides affordable medicine to patients across geographies. Over the last 8 decades, we have been fortifying our promise of ‘Caring for Life'.
Make every life thrive. You will be inspired by our purpose and pioneering spirit at Cipla. Growth, to us, is meaningful when it is holistic and has an impact beyond ourselves. Inspiring Pioneers. Championing Care. Nourishing Careers. Search jobs.
16 hours ago · Cipla is going through it 10 or 15 years ahead of others, because we are also 15 years older than they are.” While the timeframe could vary for companies, he said, “I see this reality for the ...
1 day ago · Cipla’s success in the US market is a significant growth driver. This success is attributed to new product launches, seasonal factors, and a strong market position in key assets.
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the...
3 days ago · Cipla Limited Stock Price Today, Live NSE Share Price: Get the latest Cipla Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Jun 28, 2024 · The development is a dampener for Cipla, which planned to launch Abraxane, a high-value drug used to treat pancreatic cancer, in Q4. Cipla Ltd’s shares have declined 4% after saying last week ...
Oct 27, 2023 · BENGALURU, Oct 27 (Reuters) - Cipla (CIPL.NS), India's third-largest generic drugmaker by sales, posted a bigger-than-expected rise in second-quarter profit on Friday, boosted by strength in its...
